Study Evaluating the Safety and Effects of MN-221 in Subjects Experiencing an Acute Exacerbation of Asthma
Status:
Terminated
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The objective of this clinical study is to examine the safety and effectiveness of
intravenous MN-221 compared to placebo when administered as an adjunct to standard therapy in
subjects experiencing an acute exacerbation of asthma.